LU; Wuyuan

Patent Applications and Registrations

Patent applications and USPTO patent grants for LU; Wuyuan.The latest application filed is for "tetrameric protein scaffolds as nano-carriers of therapeutic peptides for treating cancer and other diseases".

Company Profile

3.5.9

LU; Wuyuan - Baltimore MD
LU; Wuyuan - Shanghai CN
LU; Wuyuan - Clarkville MD
Lu; Wuyuan - Ellicott City MD
Lu; Wuyuan - Ellicottt City MD

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Tetrameric Protein Scaffolds As Nano-carriers Of Therapeutic Peptides For Treating Cancer And Other Diseases App 20220127335 - LU; Wuyuan ; et al.	2022-04-28
Dithiocarbamate Stapled Peptides And Methods Of Making And Use Thereof App 20220089638 - LU; Wuyuan ; et al.	2022-03-24
Inhibitors Of Type 3 Secretion System And Antibiotic Therapy App 20220008376 - LU; Wuyuan	2022-01-13
Treatment of cancer and inhibition of metastasis using hemoglobin beta subunit Grant 10,561,712 - Lu , et al. Feb	2020-02-18
Treatment Of Cancer And Inhibition Of Metastasis Using Hemoglobin Beta Subunit App 20170304410 - LU; Wuyuan ; et al.	2017-10-26
Surface-layer protein coated microspheres and uses thereof Grant 8,895,062 - De Leeuw , et al. November 25, 2	2014-11-25
p53 activator peptides Grant 8,343,760 - Lu , et al. January 1, 2	2013-01-01
Potent D-peptide Antagonists Of Mdm2 And Mdmx For Anticancer Therapy App 20120328692 - LU; Wuyuan ; et al.	2012-12-27
P53 Activator Peptides App 20110183917 - Lu; Wuyuan ; et al.	2011-07-28
Surface-layer Protein Coated Microspheres And Uses Thereof App 20090214662 - de Leeuw; Erik P.H. ; et al.	2009-08-27
Methods of treating inflammation in mammalian tissues comprising administering human alpha-defensins Grant 7,528,107 - Shi , et al. May 5, 2	2009-05-05
Human Alpha-defensins Inhibit Interleukin-1beta Release App 20080051333 - Shi; Jishu ; et al.	2008-02-28
Human neutrophil alpha-defensin 4 inhibition of HIV-1 App 20060172945 - Lu; Wuyuan ; et al.	2006-08-03

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.